Screening for fetal trisomy 21 in gestational weeks 6 and 7

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 9, 2010, Pages 1218-1221

  Madsen, Helen N ^a   Petersen, Olav B ^a   Tørring, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Down's syndrome; First trimester; Free hCG; PAPP A; Trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A; BIOLOGICAL MARKER; BIOCHEMICAL MARKER;

ARTICLE; BLOOD SAMPLING; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; TRISOMY 21; BLOOD; DOWN SYNDROME; MASS SCREENING; FETUS DISEASE; GENETIC SCREENING; MAJOR CLINICAL STUDY;

BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 77956303894     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016349.2010.489600     Document Type: Article

References (12)

1. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 1999;13:231-237
2. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG. 2003;110:281-286
3. Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides KH. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol. 2005; 192:1761-1767
4. Kirkegaard I, Petersen OB, Uldbjerg N, Torring N. Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. Prenat Diagn. 2008;28:839-844
5. Torring N. Performance of first-trimester screening between gestational weeks 7 and 13. Clin Chem. 2009;55: 1564-1567
6. Schiott KM, Christiansen M, Petersen OB, Sorensen TL, Uldbjerg N. The 'Consecutive Combined Test' - using double test from week 8 + 0 and nuchal translucency scan, for first trimester screening for Down syndrome. Prenat Diagn. 2006;26:1105-1109
7. Torring N, Jolving LR, Petersen OB, Holmskov A, Hertz JM, Uldbjerg N. Prenatal diagnostics in Arhus and Viborg Counties after implementation of first trimester risk assessment. Ugeskr Laeger. 2008;170:50-54
8. Robinson HP, Fleming JE. A critical evaluation of sonar 'crown-rump length' measurements. Br J Obstet Gynaecol. 1975;82:702-710
9. Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Ann Clin Biochem. 2002;39:567-576
10. Christiansen M, Jaliashvili I. Total pregnancy-associated plasma protein A - a first trimester maternal serum marker for Down's syndrome: clinical and technical assessment of a poly-monoclonal enzyme immunoassay. Scand J Clin Lab Invest. 2003;63:407-415
11. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal trans- lucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008;31:618-624
12. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 2005;353: 2001-2011